These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34842457)

  • 21. N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.
    Shi HZ; Xiong JS; Gan L; Zhang Y; Zhang CC; Kong YQ; Miao QJ; Tian CC; Li R; Liu JQ; Zhang EJ; Bu WB; Wang Y; Cheng XF; Sun JF; Chen H
    Clin Transl Med; 2022 Nov; 12(11):e1075. PubMed ID: 36324258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
    Zhang C; Gu L; Xiao J; Jin F
    BMC Cancer; 2023 Jul; 23(1):684. PubMed ID: 37474926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
    Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
    Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RBM15 m
    Song Y; Wu Q
    Environ Toxicol; 2023 Sep; 38(9):2155-2164. PubMed ID: 37334762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RNA m6A writer RBM15 contributes to the progression of esophageal squamous cell carcinoma by regulating miR-3605-5p/KRT4 pathway.
    Wang H
    Heliyon; 2024 Jan; 10(2):e24459. PubMed ID: 38312624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF‑κB/AP‑1 signaling pathway.
    Zhu G; Cheng Z; Huang Y; Zheng W; Yang S; Lin C; Ye J
    Int J Mol Med; 2020 Jan; 45(1):131-140. PubMed ID: 31746347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.
    Zeng X; Chen K; Li L; Tian J; Ruan W; Hu Z; Peng D; Chen Z
    Free Radic Biol Med; 2022 May; 184():135-147. PubMed ID: 35381326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.
    Qin Y; Wu S; Zhang F; Zhou X; You C; Tan F
    Environ Toxicol; 2023 Nov; 38(11):2772-2782. PubMed ID: 37551785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer.
    Liu T; Tang W; Chen Y; Liu Y; Xu D; Jiang Y; Zhou S; Qin X; Ren L; Chang W; Xu J
    Clin Med Insights Oncol; 2022; 16():11795549221104441. PubMed ID: 35898390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm.
    Fu C; Feng L; Zhang J; Sun D
    Ann Transl Med; 2022 May; 10(10):547. PubMed ID: 35722410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.
    Huang L; Liang D; Zhang Y; Chen X; Chen J; Wen C; Liu H; Yang X; Yang X; Lin S
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5095-5108. PubMed ID: 36348020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
    Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
    J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
    Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.